e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical data and COPD management
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PROMS and FEV1 as predictors of AECOPD
G. Drivas (Athens, Greece), G. Hillas (Athens, Greece), A. Papaporfyriou (Athens, Greece), M. Kaponi (Athens, Greece), K. Dimakou (Athens, Greece)
Source:
Virtual Congress 2020 – Clinical data and COPD management
Session:
Clinical data and COPD management
Session type:
E-poster session
Number:
1002
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Drivas (Athens, Greece), G. Hillas (Athens, Greece), A. Papaporfyriou (Athens, Greece), M. Kaponi (Athens, Greece), K. Dimakou (Athens, Greece). PROMS and FEV1 as predictors of AECOPD. 1002
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR®
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Are 6MWD and FEV1 the most clinically relevant measures?
Source: Annual Congress 2012 - Life's a gas: aspects of respiratory gas exchange
Year: 2012
Change in clinical COPD questionnaire (CCQ) symptoms domain score and FEV
1
predict treatment failure during hospitalisation due to COPD exacerbations
Source: Eur Respir J 2007; 30: Suppl. 51, 525s
Year: 2007
Mortality predictive variables in the short-term before a COPD exacerbation
Source: Eur Respir J 2006; 28: Suppl. 50, 177s
Year: 2006
Tiotropium: COPD exacerbations and decline in FEV1
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
BODE index as predictor of exacerbation occurrence in ambulatory patients with COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007
FEV
1
/Height
2
could be a better alternative than FEV
1
in predicting all cause mortality in patients with COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
NIMV in the treatment of COPD exacerbations: predictors of success
Source: Eur Respir J 2004; 24: Suppl. 48, 312s
Year: 2004
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD?
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Decline in FEV
1
is faster with frequent exacerbations of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 153s
Year: 2001
Closing volume predicts the FEV1 response to bronchodilators in patients with COPD
Source: Virtual Congress 2020 – Advances in lung function testing
Year: 2020
Minimal clinically important difference and predictive validity of the mMRC and mBorg in acute exacerbations of COPD
Source: International Congress 2017 – Assessing functional outcomes in chronic respiratory disease
Year: 2017
Sniff nasal inspiratory pressure as a predictor of 1-year mortality after exacerbation of COPD
Source: Virtual Congress 2020 – Muscle, exercise capacity and symptoms of chronic lung disease: a physio update
Year: 2020
Correlation of various parameters with FEV1 in the assessment of asthma severity
Source: Eur Respir J 2001; 18: Suppl. 33, 51s
Year: 2001
Walking distance is a predictor of exacerbations in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 633s
Year: 2004
Biomarkers to predict FEV1 decline in smokers and early-onset COPD.
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020
Lung function values as predictors for outcome during non-invasive ventilation in COPD patients
Source: Annual Congress 2011 - New evidence in home mechanical ventilation
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept